GlassScriptPhysician profile
Kenneth Iwuji
NPI 1477908903
$9,369.10
in general payments reported to CMS, 2019-2025
20 companies · $678 in 2025
The $678 reported for 2025 was more than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,159 · 2020: $206 · 2021: $518 · 2022: $349 · 2023: $5,291 · 2024: $1,169 · 2025: $678.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,100 · Travel and Lodging: $2,567 · Food and Beverage: $1,470.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,099.99 |
| Travel and Lodging | $2,567.37 |
| Food and Beverage | $1,470.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,951.27 | 2023-2024 | Ion, Da Vinci Surgical System |
| Astrazeneca Pharmaceuticals LP | $881.50 | 2019-2025 | Airsupra, Tezspire, Breztri |
| Glaxosmithkline, LLC. | $446.31 | 2019-2023 | Arexvy, Trelegy Ellipta |
| Actelion Pharmaceuticals US, INC. | $356.79 | 2019-2025 | Opsumit, Uptravi |
| Boehringer Ingelheim Pharmaceuticals, INC. | $271.75 | 2019-2025 | Jascayd |
| Olympus America INC. | $215.07 | 2021-2023 | Spiration Valve System |
| United Therapeutics Corporation | $183.18 | 2019-2025 | |
| Abiomed | $173.61 | 2025 | |
| Veran Medical Technologies, INC. | $169.84 | 2019-2020 | |
| Allergan, INC. | $125.74 | 2019 | |
| Amgen INC. | $118.86 | 2022 | |
| Alnylam Pharmaceuticals INC. | $96.63 | 2019 | |
| Insmed, INC. | $96.57 | 2019-2021 | |
| Csl Behring | $73.84 | 2019 | |
| Alexion Pharmaceuticals, INC. | $51.75 | 2019-2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $49.27 | 2019 | |
| Philips North America LLC | $37.02 | 2019 | |
| Astellas Pharma US INC | $35.17 | 2019-2020 | |
| Pfizer INC. | $18.67 | 2021 | |
| Grifols USA, LLC | $16.26 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Iwuji listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.